Skip to main content
All lobbying filings

RK STRATEGIES, INC.

RK STRATEGIES, INC. filed a Q2 report for ADIAL PHARMACEUTICALS, INC. on July 21, 2025, reporting $10,000 in lobbying income.

Lobbying for ADIAL PHARMACEUTICALS, INC. · Pharmaceutical company

All filings by RK STRATEGIES, INC. · Everything ADIAL PHARMACEUTICALS, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 21, 2025
Income
$10,000
What the client paid this registrant for the period.
Client based in
Virginia

Official filing document

 Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

FDA issues related to Alcohol Use Disorder

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem